NCT05994599View on ClinicalTrials.gov

Comparative Bioavailability Study of Ethinyl Estradiol/Etonogestrel Vaginal Ring

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

July 29, 2023

Primary Completion Date

December 11, 2023

Study Completion Date

December 11, 2023

Conditions
Healthy WomenFemaleContraception
Interventions
COMBINATION_PRODUCT

EVE119 vaginal ring

EVE119 (ethinyl estradiol/etonogestrel) vaginal ring delivering 0.015 mg/0.12 mg dose per day

COMBINATION_PRODUCT

Nuvaring vaginal ring

Nuvaring® (ethinyl estradiol/etonogestrel) vaginal ring delivering 0.015 mg/0.12 mg dose per day

Trial Locations (1)

Unknown

Altasciences, Mount Royal

Sponsors

Lead Sponsor

Evestra Inc.
All Listed Sponsors
lead

Evestra Inc.

INDUSTRY